Operating Expenses Summary of Celltrion, Inc.

Celltrion, Inc.'s latest annual operating expenses in 2023 was 359.46 Billion KRW , down -6.75% from previous year.
Celltrion, Inc.'s latest quarterly operating expenses in 2024 Q2 was 221.77 Billion KRW , up 35.55% from previous quarter.
Celltrion, Inc. reported a annual operating expenses of 385.49 Billion KRW in annual operating expenses 2022, up 10.48% from previous year.
Celltrion, Inc. reported a annual operating expenses of 348.93 Billion KRW in annual operating expenses 2021, up 12.89% from previous year.
Celltrion, Inc. reported a quarterly operating expenses of 217.88 Billion KRW for 2024 Q1, up 86.11% from previous quarter.
Celltrion, Inc. reported a quarterly operating expenses of 359.46 Billion KRW for 2023 FY, down -6.75% from previous quarter.

Annual Operating Expenses Chart of Celltrion, Inc. (2023 - 2007)

Historical Annual Operating Expenses of Celltrion, Inc. (2023 - 2007)

Year	Operating Expenses	Operating Expenses Growth
2023	359.46 Billion KRW	-6.75%
2022	385.49 Billion KRW	10.48%
2021	348.93 Billion KRW	12.89%
2020	309.08 Billion KRW	22.67%
2019	251.95 Billion KRW	10.62%
2018	227.77 Billion KRW	14.89%
2017	198.24 Billion KRW	34.95%
2016	146.9 Billion KRW	33.69%
2015	109.88 Billion KRW	-21.32%
2014	139.66 Billion KRW	142.16%
2013	57.67 Billion KRW	-5.19%
2012	60.83 Billion KRW	31.76%
2011	46.16 Billion KRW	32.3%
2010	34.89 Billion KRW	57.15%
2009	22.2 Billion KRW	32.34%
2008	16.78 Billion KRW	121.52%
2007	7.57 Billion KRW	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	221.77 Billion KRW	35.55%
2024 Q1	217.88 Billion KRW	86.11%
2023 FY	359.46 Billion KRW	-6.75%
2023 Q4	117.07 Billion KRW	213.97%
2023 Q1	81.74 Billion KRW	-17.71%
2023 Q3	-102.71 Billion KRW	-10.24%
2023 Q2	-93.17 Billion KRW	-213.99%
2022 Q4	99.33 Billion KRW	15.19%
2022 Q3	86.23 Billion KRW	-14.83%
2022 Q2	101.24 Billion KRW	-7.29%
2022 Q1	109.21 Billion KRW	9.79%
2022 FY	385.49 Billion KRW	10.48%
2021 Q3	83.86 Billion KRW	10.11%
2021 Q1	89.43 Billion KRW	-19.87%
2021 Q2	76.16 Billion KRW	-14.84%
2021 FY	348.93 Billion KRW	12.89%
2021 Q4	99.47 Billion KRW	18.61%
2020 Q4	111.61 Billion KRW	49.85%
2020 FY	309.08 Billion KRW	22.67%
2020 Q1	65.12 Billion KRW	-8.43%
2020 Q3	74.48 Billion KRW	28.74%
2020 Q2	57.85 Billion KRW	-11.16%
2019 Q1	55.6 Billion KRW	-28.68%
2019 FY	251.95 Billion KRW	10.62%
2019 Q3	67.15 Billion KRW	15.63%
2019 Q4	71.12 Billion KRW	5.92%
2019 Q2	58.07 Billion KRW	4.44%
2018 Q3	53.99 Billion KRW	11.38%
2018 Q4	77.96 Billion KRW	44.4%
2018 FY	227.77 Billion KRW	14.89%
2018 Q1	39.64 Billion KRW	-55.19%
2018 Q2	48.47 Billion KRW	22.28%
2017 Q2	36.07 Billion KRW	20.57%
2017 FY	198.24 Billion KRW	34.95%
2017 Q4	88.46 Billion KRW	102.08%
2017 Q3	43.77 Billion KRW	21.34%
2017 Q1	29.92 Billion KRW	-16.83%
2016 Q4	35.97 Billion KRW	-3.46%
2016 Q3	37.26 Billion KRW	9.6%
2016 Q1	39.66 Billion KRW	36.84%
2016 FY	146.9 Billion KRW	33.69%
2016 Q2	34 Billion KRW	-14.27%
2015 Q1	22.05 Billion KRW	-42.9%
2015 Q3	29.38 Billion KRW	-0.31%
2015 Q4	28.98 Billion KRW	-1.35%
2015 Q2	29.47 Billion KRW	33.66%
2015 FY	109.88 Billion KRW	-21.32%
2014 Q2	42.96 Billion KRW	106.76%
2014 FY	139.66 Billion KRW	142.16%
2014 Q4	38.61 Billion KRW	3.5%
2014 Q3	37.31 Billion KRW	-13.15%
2014 Q1	20.77 Billion KRW	45.19%
2013 Q3	17.06 Billion KRW	52.61%
2013 FY	57.67 Billion KRW	-5.19%
2013 Q4	14.31 Billion KRW	-16.12%
2013 Q1	15.12 Billion KRW	6.49%
2013 Q2	11.17 Billion KRW	-26.08%
2012 FY	60.83 Billion KRW	31.76%
2012 Q1	11.16 Billion KRW	0.0%
2012 Q3	22.69 Billion KRW	77.02%
2012 Q4	14.2 Billion KRW	-37.43%
2012 Q2	12.82 Billion KRW	14.83%
2011 Q3	9.14 Billion KRW	-23.98%
2011 Q2	12.03 Billion KRW	11.21%
2011 Q1	10.82 Billion KRW	-29.73%
2011 FY	46.16 Billion KRW	32.3%
2011 Q4	- KRW	-100.0%
2010 Q2	4.99 Billion KRW	16.07%
2010 Q1	4.3 Billion KRW	-21.38%
2010 Q3	9.28 Billion KRW	85.98%
2010 Q4	15.4 Billion KRW	65.92%
2010 FY	34.89 Billion KRW	57.15%
2009 Q4	5.46 Billion KRW	74.39%
2009 FY	22.2 Billion KRW	32.34%
2009 Q3	3.13 Billion KRW	-38.55%
2009 Q2	5.1 Billion KRW	-11.17%
2009 Q1	5.74 Billion KRW	27.69%
2008 Q1	1.53 Billion KRW	0.0%
2008 Q3	3.47 Billion KRW	47.13%
2008 Q4	4.5 Billion KRW	29.42%
2008 FY	16.78 Billion KRW	121.52%
2008 Q2	2.36 Billion KRW	53.81%
2007 Q4	- KRW	-100.0%
2007 Q2	1.24 Billion KRW	6.62%
2007 Q1	1.17 Billion KRW	0.0%
2007 FY	7.57 Billion KRW	0.0%
2007 Q3	1.48 Billion KRW	18.82%

Peer Operating Expenses Comparison of Celltrion, Inc.

Name	Operating Expenses	Operating Expenses Difference
ORIENT BIO Inc.	10.23 Billion KRW	-3413.748%
Green Cross Holdings Corporation	620.02 Billion KRW	42.023%
Green Cross Holdings Corporation	424.43 Billion KRW	15.306%
Pharmicell Co., Ltd.	14 Billion KRW	-2466.865%
Green Cross Corporation	424.43 Billion KRW	15.306%
GeneOne Life Science, Inc.	40.6 Billion KRW	-785.199%
Samsung Biologics Co.,Ltd.	638.51 Billion KRW	43.703%
SK bioscience Co.,Ltd.	154.23 Billion KRW	-133.072%
SK Biopharmaceuticals Co., Ltd.	358.33 Billion KRW	-0.317%
Prestige BioPharma Limited	63.47 Billion KRW	-466.342%

Global Stocks Search

Celltrion, Inc. (068270.KS)

Operating Expenses Summary of Celltrion, Inc.

Annual Operating Expenses Chart of Celltrion, Inc. (2023 - 2007)

Historical Annual Operating Expenses of Celltrion, Inc. (2023 - 2007)

Peer Operating Expenses Comparison of Celltrion, Inc.